The News story ‘Targeted drugs to tackle hepatitis C’ (Nature 497, 18–19; 2013) wrongly implied that the US Preventive Services Task Force considers financial costs when evaluating the risks and benefits of screening. It does not.
Additional information
The online version of the original article can be found at 10.1038/497018a
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Correction. Nature 497, 301 (2013). https://doi.org/10.1038/497301a
Published:
Issue Date:
DOI: https://doi.org/10.1038/497301a
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
